Daniel A. Peisert
Director of Finance/CFO chez ZYLA LIFE SCIENCES
Fortune : 311 617 $ au 31/03/2024
Profil
Daniel A.
Peisert is currently the CFO, Secretary, Treasurer & Director at Zyla Life Sciences LLC.
He previously worked as an Assistant Director at UBS Asset Management (Americas), Inc. and as a Finance Director and Director-Finance & Business Development at Marathon Advisors LLC and Marathon Pharmaceuticals LLC, respectively.
He also worked as an Auditor at PricewaterhouseCoopers LLP and as an Equity Analyst at Magnetar Capital LLC.
Additionally, he served as a Vice President at Advanz Pharma Corp.
Ltd.
and Advanz Pharma Corp.
(Ontario).
He was also a Research Analyst at Cupps Capital Management LLC and a Secretary & Director at SureGene LLC.
He earned his undergraduate degree from the University of Minnesota in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASSERTIO HOLDINGS, INC.
0,34% | 12/09/2023 | 324 939 ( 0,34% ) | 311 617 $ | 31/03/2024 |
Postes actifs de Daniel A. Peisert
| Sociétés | Poste | Début |
|---|---|---|
| ZYLA LIFE SCIENCES | Director of Finance/CFO | 20/05/2020 |
Anciens postes connus de Daniel A. Peisert
| Sociétés | Poste | Fin |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Chief Executive Officer | 02/01/2024 |
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 01/09/2017 |
Cupps Capital Management LLC
 Cupps Capital Management LLC Investment ManagersFinance Founded in 2002, Cupps Capital Management LLC is a registered investment advisor located in Chicago, Illinois. The firm provides discretionary investment supervisory and management services affiliated non-registered private partnership funds, institutional separate accounts, and affiliated and unaffiliated registered mutual funds. | Analyst-Equity | 28/02/2014 |
Formation de Daniel A. Peisert
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
UBS Asset Management (Americas), Inc.
 UBS Asset Management (Americas), Inc. Investment ManagersFinance UBS Asset Management (Americas) LLC (UBS AM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as UBS Global Asset Management (Americas), Inc. They are a wholly owned subsidiary of UBS Americas, Inc., ultimately owned by UBS Group AG (SIX: UBSG; NYSE: UBS) in Switzerland. UBS AM provides investment products and services to corporate and public pension plans, financial institutions and advisors, central banks, charities, foundations and individual investors around the world. | Finance |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cupps Capital Management LLC
Cupps Capital Management LLC Investment ManagersFinance Founded in 2002, Cupps Capital Management LLC is a registered investment advisor located in Chicago, Illinois. The firm provides discretionary investment supervisory and management services affiliated non-registered private partnership funds, institutional separate accounts, and affiliated and unaffiliated registered mutual funds. | Finance |
| Marathon Advisors LLC | |
Magnetar Capital LLC
 Magnetar Capital LLC Investment ManagersFinance Magnetar Capital LLC is an alternative asset manager headquartered in Evanston, Illinois. The firm was founded by Alec Litowitz and Ross Laser in 2005 and is a subsidiary of Magnetar Capital Partners LP. Magnetar Capital provides investment solutions to a wide range of investors. | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
